Hepatitis Delta Virus Causing Fulminant Hepatic Failure More Frequently Than Other Liver Diseases

Authors: Muhammad Farooq. Badar Abbasi, Arshad Ali, Ambreen Bhutto

Volume 19 | Issue 1

Published: November 6, 2026

Abstract

To study the prevalence and effect of HDV infection in Hbs Ag positive Patients Introduction: The cases of HDV infection are declining worldwide, but in Pakistan there is an increase in prevalence. Hbs Ag positive patients may be infected with HDV as co infection or super infection. The liver disease becomes severe and chances of development of acute Fulminant hepatitis increase. There was need to see the effect of HDV in Hbs Ag positive patients regarding liver damage. Therefore the study was designed to see the prevalence and effect of HDV. Material And Method: This is descriptive cross sectional study which was done in two hospitals of Karachi from January 2010 till December 2011. All Hbs Ag positive patients were included. The patients with HCV, HAV, HEV, alcoholic, metabolic, drug induced and autoimmune hepatitis were excluded. All patients went through anti HDV antibody detection test and a series of tests to determine co infection, super infection, acute fulminant hepatitis, hepatocellular carcinoma, acute hepatitis and cirrhosis. Result: In total 310 patients, the anti HDV positive patients were 24.51% (n=76). There were 65.2% male (n=202) and 34.8% (n=108) female. The co infection with HDV was 5.25% (n=17) while super infection 19.1% (n=59) with significant difference (p-value=0.002). The acute hepatitis was 25.16% (n=78), HCC was 7.4% (n=23), cirrhosis of liver 39.35% (n=122) and there was no significant difference between HDV seropositive and HDV seronegative groups. The acute Fulminant hepatitis was 4.8% (n=15) which was significantly associated with HDV seropositive group (p value =<0.001). Conclusion: Acute fulminant hepatic failure was more commonly associated with HDV seropositive group than cirrhosis, acute hepatitis and HCC.

Keywords: HDV, Acute Fulminant Hepatitis.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF